Colorectal Cancer Clinical Trials

Find Colorectal Cancer Clinical Trials Near You

Patient Engagement in Using the Technology for Self-Tracking Medication Safety Events

Status: Recruiting
Location: See location...
Intervention Type: Other, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve the goal of medication safety, they need to become vigilant partners in medication and toxicity self-monitoring, including timely reporting of medication events to clinicians when their care transitions back home. In this study, patients use an online self-monitoring platform to track their experiences or concerns about taking their medications, including their experiences with symptoms. This platform may be a useful way for patients to track problems they have when taking their medications at home and may help them take better care of their health.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participants are adult patients (aged 18 years or older)

• Diagnosed with lung, colorectal, breast, or prostate cancer

• Are currently receiving active cancer treatments

• Are self-managing one or more prescribed cancer medications

• Participants must have access to technology devices (smartphone, tablet, computer) to track their experiences or concerns about medication safety events, or their family members can help them access technology devices to track the events or concerns

• Speaks and reads English or has a support person (family member or friend) who can assist

Locations
United States
Michigan
University of Michigan Comprehensive Cancer Center
RECRUITING
Ann Arbor
Contact Information
Primary
Yun Jiang
jiangyu@umich.edu
734-763-3705
Time Frame
Start Date: 2026-01-09
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 80
Treatments
Experimental: Health services research (self-monitoring platform)
Patients use the self-monitoring platform to track medication-related safety events and issues at home for 6 months. Patients may receive relevant educational materials and resources via the platform or by email and/or receive follow-up contact from a nurse practitioner as needed over the 6 months. Patients are encouraged to continue using the platform for an additional 6 months after the study period, as desired.
Sponsors
Leads: University of Michigan Rogel Cancer Center
Collaborators: Agency for Healthcare Research and Quality (AHRQ)

This content was sourced from clinicaltrials.gov